-
2022-502691-23-00
6
2023-02-27
Ovarian cancer
-
2023-504943-15-00
4
2022-08-19
Cancer(colon cancer stage II-III, rectal cancer, and breast cancer)ove
-
2023-507029-40-00
5
2022-05-09
Genetic carriers of dilated cardiomyopathy causing variants
-
2023-507119-36-00
5
2022-05-09
Malignant melanoma of the skin in patients with locally advanced and f
-
2023-506891-28-00
5
2022-05-02
The target population of interest in this study is participants with l
-
2024-518243-38-00
5
2022-04-20
Fecal incontinence in female and male patients
-
2024-512726-28-00
6
2022-02-14
peritoneal metastases of colorectal cancer
-
2023-504166-37-00
4
2022-02-01
Advanced ovarian, tubal or peritoneal cancer.
-
2023-508963-58-00
4
2022-01-31
Symptomatic hypertrophic cardiomyopathy (HCM)
-
2024-510690-16-00
5
2022-01-31
Relapsed/refractory follicular lymphoma
-
2023-509290-22-00
6
2022-01-21
Severe Symptomatic Aortic Stenosis
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2024-512632-30-00
4
2021-12-02
X-linked hypohidrotic ectodermal dysplasia (XLHED)
-
2024-516291-16-00
3
2021-10-26
Acute myeloid lymphoma (AML), myelodysplastic syndrome (MDS), or solid
-
2024-515273-10-00
7
2021-10-19
Relapsed or refractory Multiple Myeloma (r/r MM)
-
2024-516330-35-00
5
2021-09-29
Non-Small Cell Lung Cancer
-
2024-514524-16-00
5
2021-05-11
Aetiological treatment of moderate-severe intermitent or persistent al
-
2023-506215-17-00
4
2021-05-03
Amyotrophic Lateral Sclerosis
-
2023-508101-24-00
5
2019-08-01
Lymphoblastic lymphoma
-
2024-516110-38-00
5
2018-03-06
Hepatoblastoma and Hepatocellular Carcinoma
-
2022-502706-33-00
6
2018-01-10
Patients with invasive breast cancer in early stages
-
2024-512222-28-00
10
2015-06-02
Newly diagnosed with an intracranial or spinal ependymoma (all WHO gra
-
2024-518254-16-00
5
2013-03-01
Acute Myeloid Leukemia (Pediatric 0-18 years)
-
2024-520155-24-00
4
2025-10-16
Metastatic castration resistant prostate cancer (mCRPC)